Abciximab: IIb or not IIb, is that still the question?
Patel, S.; Perera, D.; Redwood, S.
International Journal of Clinical Practice 57(1): 5-7
2003
ISSN/ISBN: 1368-5031 PMID: 12587933 Document Number: 566081
Document emailed within 1 workday
Related Documents
Chen, W-Hong.; Kaul, U.; Leung, S-Kin.; Lau, Y-Kong.; Tan, H-Cheem.; Leung, A.Wai-Suen.; Lee, M.Kang-Yin.; Li, S-Kin.; Ng, W.; Lee, P-Yin.; Lam, K-Fai.; Tse, H-Fat.; Lau, C-Pak. 2005: A randomized, double-blind, placebo-controlled trial of abciximab for prevention of in-stent restenosis in diabetic patients after coronary stenting: results of the ASIAD (Abciximab in Stenting Inhibits restenosis Among Diabetics) Trial Journal of Invasive Cardiology 17(10): 534-538Howard, D.J.; Kerin, R.A. 1994: Question Effects on Question Generation and the Mediation of Attitude Change Psychological Reports 75(1 Pt 1): 209-210
Johnson, A.L.; Villanti, A.C.; Glasser, A.M.; Pearson, J.L.; Delnevo, C.D. 2019: Impact of Question Type and Question Order on Tobacco Prevalence Estimates in US Young Adults: A Randomized Experiment Nicotine and Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco 21(8): 1144-1146
Mascia, L.; Terragni, P. 2011: Tracheostomy in ICU patients: question of timing is question of indication Minerva Anestesiologica 77(12): 1137-1138
Schelling, H.R.; Martin, M. 2008: Attitudes toward one's own aging: a question of age or a question of resources? Zeitschrift für Gerontologie und Geriatrie 41(1): 38-50
Kevin, R. Cox 1984: Space and the urban question: P. Saunders: Social Theory and the Urban Question (1981)1 Political Geography Quarterly 3(1): 77-84
Tan, H.C.; Lim, Y.T.; Lim, T.T.; Cheng, A.; Chia, B.L. 2000: The use of abciximab in coronary angioplasty--an Asian centre's experience Singapore Medical Journal 41(2): 69-73
Applegate, R.J.; Grabarczyk, M.A.; Sane, D.C.; Sacrinty, M.T.; Goodin, J.E.; Statonk, G.S.; Baki, T.T.; Gandhi, S.K.; Kutcher, M.A.; Little, W.C. 2006: PCi with and without abciximab after upstream eptifibatide use: outcomes in high-risk patients Journal of Invasive Cardiology 18(12): 604-613
Conrad, M.E.; Umbreit, J.N.; Moore, E.G. 1998: Integrin beta3 blockade with abciximab and protection from myocardial ischemic events JAMA 279(3): 195-196
Goklaney, A.K.; Murphy, J.D.; Hillegass, W.B. 1998: Abciximab therapy in percutaneous intervention: economic issues in the United States European Heart Journal 19 Suppl D: D52-D58
Kassas, S.; Cheema, A.A. 2004: Use of abciximab in massive pulmonary embolism with free-floating, intra-cardiac thrombi Thrombosis and Haemostasis 92(4): 883-885
Coto, H. 2000: Platelet receptor glycoprotein IIb/IIIa inhibition with eptifibatide in a patient with thrombocytopenia after treatment with abciximab Journal of Invasive Cardiology 12(10): 528-531
Muhlestein 1996: Cost-EffectiveUtilization of Abciximab During Coronary Angioplasty in the Setting of Unstable Angina: a Case Study Journal of Invasive Cardiology 8 Suppl B: 48b-50b
Weinstock, B.S. 2002: Facilitated percutaneous intervention following combination therapy with reteplase and abciximab for acute myocardial infarction Journal of Invasive Cardiology 14(2): 100-104; Quiz: 104-105
Kereiakes, D.J.; Fry, E.; Matthai, W.; Niederman, A.; Barr, L.; Brodie, B.; Zidar, J.; Casale, P.; Christy, G.; Moliterno, D.; Lengerich, R.; Broderick, T.; Shimshak, T.; Cohen, M. 2000: Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: "NICE guys finish first" Journal of Invasive Cardiology 12 Suppl A: 1a-5a
Bovenzi, F.; De Luca, L.; Signore, N.; Fusco, F.; de Luca, I. 2003: Abciximab for the treatment of an acute thrombotic coronary occlusion during stent implantation in a patient with severe hemophilia B Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 4(10): 728-730
Thuraisingham, S.; Tan, K.H. 1999: Dissolution of thrombus formed during direct coronary angioplasty with a single 10 mg intracoronary bolus dose of abciximab International Journal of Clinical Practice 53(8): 604-607
Bright, J.McIntosh.; Dowers, K.; Powers, B.E. 2003: Effects of the glycoprotein IIb/IIIa antagonist abciximab on thrombus formation and platelet function in cats with arterial injury Veterinary Therapeutics: Research in Applied Veterinary Medicine 4(1): 35-46
Bajaj, R.R.; Mohammad, A.; Hong, T.; Irfan, A.; Sharieff, W.; Bagnall, A.; Christie, J.-A.; Kutryk, M.J.B.; Chisholm, R.J.; Cheema, A.N. 2010: Comparison of abciximab and eptifibatide on angiographic and clinical outcomes in rescue percutaneous coronary intervention for failed fibrinolytic therapy Journal of Invasive Cardiology 22(8): 347-352
Glatt, B.; Luycx-Bore, A.; Guyon, P.; Chevalier, B.; Jullien, T.; Royer, T.; Hénequin, B.; Herlin, C.; Belotte, F.; Sebbah, J.L. 1999: Pre-hospitalization treatment with Abciximab in the preparation of patients for primary angioplasty in the acute phase of myocardial infarct. Immediate and long-term (one month) results Archives des Maladies du Coeur et des Vaisseaux 92(10): 1301-1308